Quality of life in patients with localised prostate cancer after either computerassisted surgery or radiotherapy with protons and photons.

Not Applicable

• Conditions: C61; Malignant neoplasm of prostate

• Registration Number: DRKS00003569
• Lead Sponsor: rologische Universitätsklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting withdrawn before recruiting started
• Sex: Male
• Target Recruitment: 120

Inclusion Criteria

1. ECOG Performance Status 0 or 1
2. informed concent
3. prostate cancer (4. ability to read and answer German questionnaires

Exclusion Criteria

1. Medical reasons against one of the therapies
2. Other treatments of prostate cancer
3. Metastases
4. Life expectancy < 5 years
5. Patients with legal guardian
6. Participation in other studies that could influence the results
7. Cardiac pacemaker

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life after treatment and after 2 weks, 3, 6, 9 and 12 month. Questionnaires: EORTC-C30, EORTC-PR25, ICS, IIEF5, PHQ, CCAT-P.

Secondary Outcome Measures

Name	Time	Method
Before, directly after and 2 weeks, 3 month, 6 month ans 1 year after treatment:<br>Biochemical relapse-free prostate-specific survival<br>Side effects (ICS, IIEF5)<br>Depression (PHQ)<br>Anxiety (PHQ)<br>Contentment (Distress-scale, CCAT-P, interview)<br>fear of progression (PA-F-KF)<br>Contentment of spouse (Distress-scale, EPIC, PHQ, interview)<br>